Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial,Allergy

当前位置： X-MOL 学术 › Allergy › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial
Allergy ( IF 12.6 ) Pub Date : 2020-02-23 , DOI: 10.1111/all.14218
Hongfei Lou _{1,

2} , Yanran Huang _{1,

2} , Yuhui Ouyang _{2,

3} , Yuan Zhang _{2,

3} , Lin Xi _{2,

3} , Xiaohan Chu _{1,

2} , Yang Wang ₂ , Chengshuo Wang _{1,

2} , Luo Zhang _{1,

2,

3}

Affiliation

Artemisia annua is an important autumnal pollen allergen for seasonal allergic rhinitis (SAR) in northern China. To date, no study has investigated allergen immunotherapy with A annua. We aimed to investigate the efficacy and mechanisms underlying A annua‐sublingual immunotherapy (SLIT).

更新日期：2020-02-23

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11